Passage Bio, Inc. ( PASG) - Stock Earnings
PASG Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
PASG Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -13.0 million USD | — USD |
| 2026Q1 | -7.6 million USD | — USD |
| 2026Q2 | -7.8 million USD | — USD |
| 2026Q4 Est. | — | — |
PASG Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -102.1 million USD | — USD |
| 2024 | -64.8 million USD | — USD |
| 2025 | -45.5 million USD | — USD |
| 2026 Est. | — | — |
PASG
Price: $3.37
52 week price:
Earnings Per Share: -11.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 271900
Market Capitalization: 13.2 million